EOLS (Evolus) FFO per Share


EOLS Evolus Inc EOLS
68 GF Score
Price $6.61
GF Value $13.67
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Evolus FFO per Share?

FFO per Share only applies to REITs.

EOLS
68GF Score
Evolus Inc EOLS
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Evolus (EOLS) Overvalued in 2026?

Based on GuruFocus' analysis, Evolus stock appears to be undervalued. The current stock price of $6.61 is trading 51.6% below its estimated GF Value™ of $13.67. GuruFocus considers Evolus to be Possible Value Trap.

Key valuation signals for EOLS:

  • FFO per Share:
  • GF Value™: $13.67 vs. price of $6.61 (51.6% below fair value)
  • GF Score™: 68/100 with 4 warning signs

No single metric tells the full story. See the EOLS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Evolus Business Description

Other Exchanges EVL:Germany
Address 520 Newport Center Drive, Suite 1200, Newport Beach, CA, USA, 92660
Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.
68GF Score

Get the complete analysis for EOLS

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.61
Price
$13.67
GF Value